Long-chain omega-3 fatty acids and blood pressure

American Journal of Hypertension

Volumn 24, Issue 10, 2011, Pages 1121-1126

  Liu, James C ^a   Conklin, Sarah M ^b   Manuck, Stephen B ^a   Yao, Jeffrey K ^c   Muldoon, Matthew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ALLEGHENY COLLEGE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ambulatory; blood pressure; blood pressure monitoring; docosahexaenoic acid; eicosapentaenoic acid; hypertension; omega 3 fatty acids

Indexed keywords

DOCOSAHEXANENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; SODIUM; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CAPILLARY GAS CHROMATOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULSE RATE; RACE DIFFERENCE; SELF REPORT; SEX DIFFERENCE; SODIUM INTAKE;

ADULT; BLOOD PRESSURE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREHYPERTENSION; REGRESSION ANALYSIS;

EID: 80052961035     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.120     Document Type: Article

References (32)

1. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007; 137: 855-859. (Pubitemid 46596878)
2. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J 2009; 85:84-90.
3. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008; 10:503-509.
4. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010; 376:540-550.
5. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-455.
6. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090-1098. (Pubitemid 46483662)
7. Massaro M, Scoditti E, Carluccio MA, De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids 2008; 79:109-115.
8. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747-2757.
9. Mori TA, Beilin LJ. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001; 12:11-17. (Pubitemid 32121279)
10. Borghi CC, Arrigo FG. Recent evidence of the role of omega-3 polyunsaturated fatty acids on blood pressure control and hypertension-related complications. Future Lipidology 2006; 1:569-577.
11. Agriculture USDo. What We Eat In America. 2011; Available from:
12. Mori TA. Omega-3 fatty acids and blood pressure. Cell Mol Biol (Noisy-le-grand) 2010; 56:83-92.
13. Search on DHA and tablet supplements. 2011. Available from: http://www.amazon.com/s/ref=nb-sb-ss-i-3-17?url=search-alias%3Daps&field- keywords= fish+oil+capsules&sprefix=fish+oil+capsules
14. Theobald HE, Goodall AH, Sattar N, Talbot DC, Chowienczyk PJ, Sanders TA. Lowdose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 2007; 137:973-978. (Pubitemid 46596896)
15. Dokholyan RS, Albert CM, Appel LJ, Cook NR, Whelton P, Hennekens CH. A trial of omega-3 fatty acids for prevention of hypertension. Am J Cardiol 2004; 93:1041-1043. (Pubitemid 38479464)
16. Ueshima H, Stamler J, Elliott P, Chan Q, Brown IJ, Carnethon MR, Daviglus ML, He K, Moag-Stahlberg A, Rodriguez BL, Steffen LM, Van Horn L, Yarnell J, Zhou B; INTERMAP Research Group. Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study. Hypertension 2007; 50:313-319. (Pubitemid 47205779)
17. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A. Ambulatory blood pressure monitoring in mild hypertension. Circulation 1995; 91:2852-2853.
18. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546. (Pubitemid 29380290)
19. Yao JK, Leonard S, Reddy RD. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 2000; 42:7-17. (Pubitemid 30116755)
20. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328:538-545. (Pubitemid 23053830)
21. Preacher KJ, Leonardelli GJ. Calculation for the Sobel Test. 2010 Available from:
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
23. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999; 34:253-260. (Pubitemid 29409224)
24. Bao DQ, Mori TA, Burke V, Puddey IB, Beilin LJ. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 1998; 32:710-717. (Pubitemid 28480549)
25. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 2009; 7:330-337.
26. Radaelli A, Cazzaniga M, Viola A, Balestri G, Janetti MB, Signorini MG, Castiglioni P, Azzellino A, Mancia G, Ferrari AU. Enhanced baroreceptor control of the cardiovascular system by polyunsaturated Fatty acids in heart failure patients. J Am Coll Cardiol 2006; 48:1600-1606. (Pubitemid 44550076)
27. Kimura S, Minami M, Togashi M, Hamaue N, Endo T, Hirafuji M, Yamada M. Antihypertensive effect of dietary docosahexa-enoic acid (22: 6n-3) in strokeprone spontaneously hypertensive rats. Biog Amines 1995; 11:195-203.
28. Grassi G, Seravalle G, Bertinieri G, Turri C, Dell'Oro R, Stella ML, Mancia G. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 2000; 18:587-593. (Pubitemid 30303490)
29. Begg DP, Sinclair AJ, Stahl LA, Garg ML, Jois M, Weisinger RS. Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hypertens 2010; 23:125-128.
30. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23:1052-1060.
31. Palatini P, Julius S. The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep 2009; 11:199-205.
32. Chen JM, Heran BS, Perez MI, Wright JM. Blood pressure lowering efficacy of betablockers as second-line therapy for primary hypertension. Cochrane Database Syst Rev 2010; CD007185.